Lv1
100 积分 2021-10-22 加入
CD44 in Bone Metastasis Development: A Key Player in the Fate Decisions of the Invading Cells?
20天前
已完结
Discovery of Novel CXCR2 Inhibitors Using Ligand-Based Pharmacophore Models
1个月前
已完结
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial
1个月前
已完结
Inducible nitric oxide synthase (iNOS)-activated Cxcr2 signaling in myeloid cells promotes TGFβ-dependent squamous cell carcinoma lung metastasis
1个月前
已完结
Inducible nitric oxide synthase (iNOS)-activated Cxcr2 signaling in myeloid cells promotes TGFβ-dependent squamous cell carcinoma lung metastasis
1个月前
已完结
KRAS: From undruggable to a druggable Cancer Target
1个月前
已完结
Targeting the untargetable KRAS in cancer therapy
1个月前
已完结
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
2个月前
已完结
Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial–Mesenchymal Transition, and Metastasis
2个月前
已完结
HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of CD44 during epithelial-mesenchymal transition
2个月前
已完结
皖公网安备34019202002308
